Skip to content
10-Q

Quarterly Report

MAP PHARMACEUTICALS, INC.

0001193125-12-218884

← back to feed
Filed
May 8, 2012 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Apr 30, 2012 30.66M sh
Capex Q1 2012 · Mar 31, 2012 $1.36M
Capex Q1 2012 · Mar 31, 2012 $15.72M
Capex Q1 2012 · Mar 31, 2011 $1.23M
Operating Cash Flow Q1 2012 · Mar 31, 2012 −$18.65M
Operating Cash Flow Q1 2012 · Mar 31, 2012 −$179.47M
Operating Cash Flow Q1 2012 · Mar 31, 2011 $41.55M
Cash And Equivalents Q1 2012 · Mar 31, 2012 $79M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $98.82M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $114.85M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $76.01M
Stockholders Equity Q1 2012 · Mar 31, 2012 $24.19M
Stockholders Equity Q1 2012 · Dec 31, 2011 $39.55M
Current Liabilities Q1 2012 · Mar 31, 2012 $11.05M
Current Liabilities Q1 2012 · Dec 31, 2011 $14.14M
Total Liabilities Q1 2012 · Mar 31, 2012 $63.48M
Total Liabilities Q1 2012 · Dec 31, 2011 $67.79M
Current Assets Q1 2012 · Mar 31, 2012 $80.23M
Current Assets Q1 2012 · Dec 31, 2011 $100.22M
Total Assets Q1 2012 · Mar 31, 2012 $87.67M
Total Assets Q1 2012 · Dec 31, 2011 $107.34M
Sga Expense Q1 2012 · Mar 31, 2012 $7.91M
Sga Expense Q1 2012 · Mar 31, 2012 $92.88M
Sga Expense Q1 2012 · Mar 31, 2011 $4.84M
Rd Expense Q1 2012 · Mar 31, 2012 $10.96M
Rd Expense Q1 2012 · Mar 31, 2012 $262.09M
Rd Expense Q1 2012 · Mar 31, 2011 $11.57M
Net Income Q1 2012 · Mar 31, 2012 −$17.84M
Net Income Q1 2012 · Mar 31, 2012 −$278.33M
Net Income Q1 2012 · Mar 31, 2011 −$16M
Operating Income Q1 2012 · Mar 31, 2012 −$17.84M
Operating Income Q1 2012 · Mar 31, 2012 −$276.71M
Operating Income Q1 2012 · Mar 31, 2011 −$15.85M
Revenue Q1 2012 · Mar 31, 2012 $1.03M
Revenue Q1 2012 · Mar 31, 2012 $78.26M
Revenue Q1 2012 · Mar 31, 2011 $558K